logo

Azithromycin oral suspension 40 mg/ml - SUSPENDED

Contract award notice · Finland · Last reported Dec 2025

Source: TED Europa

Tender
Contract Award Notice

Finnish Institute for Health and Welfare, later referred to as THL or Customer, requested tenders for "Azithromycin oral suspension 40mg/ml" to the rescEU Medical -project. The subject of the procurement is Article in accordance with the following requirements:

  • The subject of tender: Azithromycin oral suspension 40 mg/ml (15 ml, oral suspension ATC J01FA10)
  • Oral liquid dosage forms
  • Active
Status
Closed
Sector
Hospital
Location
Finland
Updated
3 Nov 2026
Source
TED Europa

ConstructChat

Ask ConstructChat about Azithromycin oral suspension 40 mg/ml - SUSPENDED

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Tender Information FAQ

Tender Information

3 Q
The tender “Azithromycin oral suspension 40 mg/ml - SUSPENDED” is a tender record in Taiyo, linked to the Hospital sector. It is issued for works, goods, or services related to Finland.

Participants

Not available for this record.

Status

Original status

contract award notice

Taiyo status

Closed

Taiyo last update

2026-11-03

Contact

Not available for this record.

Description

Description

Finnish Institute for Health and Welfare, later referred to as THL or Customer, requested tenders for "Azithromycin oral suspension 40mg/ml" to the rescEU Medical -project. The subject of the procurement is Article in accordance with the following requirements: - The subject of tender: Azithromycin oral suspension 40 mg/ml (15 ml, oral suspension ATC J01FA10) - Oral liquid dosage forms - Active pharmaceutical ingredient: Azithromycin - Strength: 40 mg/ml - Pharmaceutical form: 15 ml oral suspension, bottle The tender shall consist of one (1) Article. The Scope of procurement is described in more detail in Annex 1. The minimum requirements for the Article is described in Annex 1.1. The Contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the Contract has been signed by contracting parties and expires when all contractual duties of the Contract have been performed. Quantity for the Articles is described in Annex 7 (restricted, TL IV). In addition to the quantity of the Articles indicated in the Annex 7, the Customer shall be entitled to purchase 100 % extra to the original quantities (later referred as "Option") described in the Annex 7. The decision to exercise the Option is in the Customer´s sole discretion. Customer should exercise the Option in part or in whole. The Customer shall notify the Supplier at the latest by the end of September 2026 if it wishes to take on the Option. The delivery schedule for the Option shall be agreed separately between the Contracting Parties. Nevertheless, the Supplier shall not be obliged to agree to deliver the Option to the Customer. Please note that all times given in the Call for tenders refer to local time in Finland. Call for tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Description of the rotation Annex 2.1 Quality scoring table Annex 3 Contract Annex 4 Security annex Annex 5 JYSE 2025 SUPPLIES Annex 6 Confidentiality commitment Annex 7 Quantity of the Articles (restricted, TL IV) Please note that the numbering of the annexes differs between the Contract and the Call for tenders. The numbering of the Annexes to the Contract is based on the order of precedence applied in the Contract.

Original sector

Medical equipments, pharmaceuticals and personal care products, Medical equipments, pharmaceuticals and personal care products

Location

Country

Finland

Source

Source

TED Europa

URL

More Details

Record type

Tender

Sector

Hospital

Article published date

2025-12-22

More on this tender

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this tender
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this tender